Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada
NCT04080856 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2022-09-28
Summary
The objective of this study is to evaluate real-world effectiveness of elagolix in Canadian women with endometriosis.
Conditions
- Endometriosis
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
ABBVIE INC. · AbbVie
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-04
- Primary Completion
- 2021-09-27
- Completion
- 2021-09-27
Countries
- Canada
Study Locations
More Related Trials
-
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
NCT01931670 ·Status: COMPLETED ·Phase: PHASE3
-
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain
NCT04333576 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain
NCT05648669 ·Status: UNKNOWN ·Phase: PHASE3
-
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
NCT01620528 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Elagolix in Women With Endometriosis
NCT00973973 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain
NCT03213457 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated Pain
NCT06076486 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain
NCT03343067 ·Status: TERMINATED ·Phase: PHASE3
-
Cardiovascular Disease Risk in Women With Endometriosis
NCT03746535 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
NCT01441635 ·Status: COMPLETED ·Phase: PHASE2
-
Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis
NCT00437658 ·Status: COMPLETED ·Phase: PHASE2
-
Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain
NCT04372121 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb
NCT04614246 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.
NCT03992846 ·Status: COMPLETED ·Phase: PHASE3
-
Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6)
NCT04335591 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
NCT03886220 ·Status: COMPLETED ·Phase: PHASE4
-
Elagolix for Fertility Enhancement Clinical Trial
NCT04039204 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
NCT01817530 ·Status: COMPLETED ·Phase: PHASE2
-
ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis
NCT01301885 ·Status: RECRUITING
-
Efficacy of Cryoablation of Abdominal Wall Endometriosis
NCT03627676 ·Status: UNKNOWN ·Phase: NA
-
A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis
NCT00244452 ·Status: COMPLETED ·Phase: PHASE2
-
BGS649 Monotherapy in Moderate to Severe Endometriosis Patients
NCT01190475 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Trace Elements in the Treatment of Endometriosis: a Pilot Study
NCT02437175 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical and Molecular Study of Endometriosis and Adenomyosis
NCT04481321 ·Status: RECRUITING
-
An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
NCT02925494 ·Status: COMPLETED ·Phase: PHASE3